SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-la

about

SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-la

Item

http://www.wikidata.org/entity/Q49344179

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

SESOTHO trial ("Switch Either ...... enter, parallel-group, open-la

@en

SESOTHO trial ("Switch Either ...... enter, parallel-group, open-la

@nl

type

Item

label

SESOTHO trial ("Switch Either ...... enter, parallel-group, open-la

@en

SESOTHO trial ("Switch Either ...... enter, parallel-group, open-la

@nl

prefLabel

SESOTHO trial ("Switch Either ...... enter, parallel-group, open-la

@en

SESOTHO trial ("Switch Either ...... enter, parallel-group, open-la

@nl

P1476

SESOTHO trial ("Switch Either ...... enter, parallel-group, open-la

@en

P2093

Alain Amstutz

http://www.w3.org/2001/XMLSchema#string

Beatrice Achieng

http://www.w3.org/2001/XMLSchema#string

Bienvenu Lengo Nsakala

http://www.w3.org/2001/XMLSchema#string

Fiona Vanobberghen

http://www.w3.org/2001/XMLSchema#string

Josephine Muhairwe

http://www.w3.org/2001/XMLSchema#string

Katleho Tlali

http://www.w3.org/2001/XMLSchema#string

Kyaw Thin

http://www.w3.org/2001/XMLSchema#string

Lebohang Sao

http://www.w3.org/2001/XMLSchema#string

Mamorena Sepeka

http://www.w3.org/2001/XMLSchema#string

Tracy Renée Glass

http://www.w3.org/2001/XMLSchema#string

P2860

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis

Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia.

Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy

Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremia.

Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings

P2888

s12879-018-2979-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-018-2979-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Niklaus Daniel Labhardt

Manuel Battegay

Thomas Klimkait

P577

2018-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101002213

http://www.w3.org/2001/XMLSchema#string

P698

29433430

http://www.w3.org/2001/XMLSchema#string

P932

5810070

http://www.w3.org/2001/XMLSchema#string